Background: A peripheral extracorporeal membrane oxygenator (p-ECMO) has been developed to support patients who are dying due to a serious cardiopulmonary condition. This analysis was planned to define the clinical situation in which the patient benefits most from a p-ECMO. Material and Methods: Between June 2007 and Aug 2009, a total of 41 adult patients used the p-ECMO. There were 23 males and 18 females (mean age 54.4±15.1 years). All patients had very unstable vital signs with hypoxia and complex cardiac problems. We divided the patients into 4 groups. In the first group, a p-ECMO was used as a bridge to cardiac operation. In the second group, patients did not have the opportunity to undergo any cardiac procedures; nevertheless, they were treated with a p-ECMO. In the third group, patients mostly had difficulty in weaning from CPB (cardiopulmonary bypass) after cardiac operation. The fourth group suffered from many complications, such as pneumonia, bleeding, infections, and LV dysfunction with underlying cardiac problems. All cannulations were performed by the Seldinger technique or cutting down the femoral vessel. A long venous cannula of DLP Ⓡ (Medtronic Inc, Minneapolis, MN)
INTRODUCTION
Strikingly rapid development in the techniques of cardiothoracic surgery now allows aggressive interventions for patients with high risks for whom previously only conservative management could be applied. However, in such cases, cardiac arrest or cardiogenic shock may easily occur.
Proper management of circulation and vital signs postoperatively is crucial to determining the prognosis and outcome of surgery.
Often proper perfusion and vital signs cannot be managed by a sufficient amount of medication such as digitalis or vasoconstrictors. Even an intra-aortic balloon pump (IABP) sometimes may not be able to improve circulation or vital signs. Such an emergent condition may be handled by a ventricular assist device (VAD) or extracorporeal membrane oxygenation (ECMO). However, such conventional mechanical cardiopulmonary support devices are only operated by cardiothoracic surgeons or by a perfusionist. Also, the duration of preparation takes quite a bit of time. Thus, it is very difficult to apply in an emergency in which cardiopulmonary resuscitation is performed. Furthermore, those devices have demonstrated a low survival rate, regardless of their aggressive methods of management [1] . Postoperative complications arising from using a cardiopulmonary bypass system (CPB) include postcardiotomy cardiogenic shock (PCS), which interrupts weaning from the CPB, uncontrolled hemorrhage and arrhythmia, and even cardiac arrest. These complications may develop with a frequency of about 2∼8% after open cardiothoracic surgery. Thus, it has been suggested that several supportive devices be developed, which may assist in weaning from CPB postoperatively [2] .
Recent supplementation of automated percutaneous cardiopulmonary support (PCPS) has ameliorated management of life support in patients with cardiogenic shock, cardiac arrest, adult respiratory distress, aspiration burns, or drug-induced myocarditis [3, 4] . Peripheral extracorporeal membrane oxygenation (p-ECMO) not only complements the weakness of conventional devices but also warrants bedside procedure. It results in faster management of circulation and vital signs than the conventional method does; thus, the p-ECMO has become a very effective device for managing patients with cardiac arrest or cardiogenic shock in-hospital [3, 5] .
This study investigates the usefulness and clinical application of the p-ECMO, analyzing clinical cases in which p-ECMO was applied to manage conditions and complications caused by cardiogenic shock.
MATERIAL AND METHODS
From June, 2007 to October, 2009, p-ECMO was used for a total of 41 patients who showed cardiogenic shock or cardiac arrest, and their medical records were analyzed retrospectively. For the p-ECMO, an emergent bypass system (CAPIOX EBS; Teramo Inc, Tokyo, Japan) was used. The patients were divided into 4 different groups (Table 1) . Group A included patients to whom p-ECMO was applied right after undergoing CPR and before cardiotomy due to cardiogenic shock occurred from coronary, valvular, or aortic diseases. All patients exhibited systolic blood pressure below 80 mmHg for over 30 min along with mental changes, oliguria, or other symptoms and signs related to peripheral vasoconstriction. They did not respond to a full administration of inotropes or vasopressors. Also, blood gas analysis displayed pO2 below 60 mmHg despite having O2 fully administered. CPR was performed for all patients exhibiting cardiac arrest or clinical conditions requiring resuscitation.
Most patients fit into the diagnostic criteria for cardiogenic shock, but afterward septic shock was observed in two cases.
One case was confirmed in which hypovolemic shock occurred along with cardiogenic shock. For groups A, B, and D, p-ECMO was applied as a bedside procedure, whereas in group C, it was performed in an operating room. To make a percutaneous route for p-ECMO, Seldinger's method was generally used. However, in two cases Seldinger's method had failed to obtain vascular access, so the femoral artery and Short-term Mechanical Circulatory Support with a Centrifugal Pump 
Group A=Patients that adopted a peripheral ECMO as a bridge to cardiac operation; Group B=Patients that did not have chance to undergo any cardiac procedures, nevertheless they were applied to peripheral ECMO; Group C=Patients that mostly had difficulty in being weaned from CPB (cardiopulmonary bypass) after cardiac operation; Group D=Patients suffered from many complications, such as pneumonia, bleeding, infections and LV dysfunction. as vital signs and use of inotropes. In the cases of group C, the same method was applied to achieve vascular access, except that the cardiotomy site was closed after obtaining access. Weaning from the p-ECMO was attempted when gradual reduction of blood flow did not provoke any symptoms or signs of cardiogenic shock without increasing doses of digitalis or of inotropes. As the catheter was taken out, the catheter insertion site was compressed in a sterile condition, until either hemorrhage or subcutaneous edema was no longer observed. Vascular suture was performed for the two cases in which vascular dissection was applied. Administration of heparin was stopped after removing the cannula, but neutralization using protamine was not attempted.
The clinical manifestation and study result of applying p-ECMO to the above patients were analyzed. 
RESULTS
The mean age of patients in this study group was 54. (Table 2) .
Furthermore, there were a total of 10 cases that were successfully weaned from p-ECMO but expired from unfavorable underlying cardiac disease. In group A, there were five cases:
one ascending aorta replacement due to ascending aortic dissection, one cardiac transplantation due to dilated cardiomyopathy, one removal of pulmonary embolus due to acute pulmonary embolism that occurred after total knee replacement, and two coronary artery bypass grafts due to acute myocardial infarction and ischemic heart disease. In group C, there were one case of aortic valvular replacement, one ascending aorta replacement and aortic valvuloplasty, and one cardiogenic shock that occurred during re-operation of a mitral valvular replacement due to postoperative hemorrhage. In Short-term Mechanical Circulatory Support with a Centrifugal Pump group D was observed one case of cardiogenic shock that occurred in a patient with atherosclerotic coronary disease and ureteroepithelioma, and one of pulmonary edema that occurred after aortic valvular replacement ( Table 3 ).
The major cause of death was due to multiple organ failure due to irreversible cardiac damage resulting low cardiac output syndrome and cardiac failure. In addition, two cases of sepsis were confirmed in the follow-up lab tests. IABP was applied to a total of 12 cases (29.2%). Moreover, 3 cases (7.3%) that simultaneously developed acute renal failure were applied continuous renal replacement therapy (CCRT).
Cardiac transplantation was performed in two cases after p-ECMO (4.8%). A long-term follow-up revealed the patient with DCMP in group A had expired, receiving medical care in an outpatient department. On the other hand, the DCMP patient in group C is currently being observed successfully in the outpatient department.
Sex, days of hospital stay, and application of IABP were not statistical factors affecting survival rate or weaning from p-ECMO. However, age over 70 years increased mortality and interfered with weaning from p-ECMO (p=0.037). The survival rate of 41 patients was 21.9% (n=9), and the rate of weaning was 46.3% (n=19). Group A, in which p-ECMO was used preoperatively to correct the underlying heart condition, demonstrated a higher survival rate (n=4, 40%) and weaning rate (n=9, 90%) than the other groups. Group B, which was indicated to receive surgical treatment but it could not be attempted, exhibited the lowest survival rate (n=1, 7%) and weaning rate (n=1, 7%). Also, group C, in which p-ECMO was applied post-cardiotomy to help wean from CPB, showed a survival rate of 25% (n=2) and a weaning rate of 62.5% (n=5). Group D displayed a survival rate of 22.2% (n=2) and a weaning rate of 44.4% (n=4).
DISCUSSION
In the early 1970's, extracorporeal life support (ECLS) us-− 14 − ing extracorporeal membrane oxygenation (ECMO) was introduced. A large number of patients could receive extensive supportive care, and it is currently known to be the fastest and most cost-effective method of respiratory support for both adults and children [6] . Furthermore, the persistent efforts of cardiothoracic surgeons has resulted in a rapid development in cardiothoracic surgical techniques, allowing surgical treatment for diseases previously considered contra- The most important factor in either ECLS or PCPS applied to patients with unstable cardiopulmonary conditions is the membrane oxygenator of which the ECMO system is composed. Development of bioengineering for oxygentors has increased the survival of patients with cardiopulmonary failure and the uses of ECLS or PCPS, greatly valuable to cardiothoracic surgeons [9] . The improvement of PCPS has enabled the maintenance of the blood supply just adequate for perfusion to vital organs, and it has decreased the myocardial oxygen demand. Several studies have reported that cardiothoracic surgery successfully carried out in very unstable cardiac conditions [10, 11] .
Such PCPS nowadays was indicated to unresponsive to conventional cardiopulmonary resuscitation [5] . This is found to be particularly useful in patients who require PCI due to ischemic heart disease but in whom cardiogenic shock or cardiac arrest occurred. Previously, a large number of patients with ischemic heart diseases, such as coronary artery disease, had expired before an appropriate intervention, like PCI. Even when re-perfusion was achieved, very severe complications, damage to vital organs, and disturbances in consciousness had resulted in poor prognosis. However, an aggressive approach by PCPS has been noted, for which not only the survival rate has been increased, but also the damage to vital organ has been minimized. Up-to-date research on the application of PCPS in PCI or CABG has shown a 25∼76% of success rate [12] [13] [14] [15] . The study done in Korea by Rhee, Il in 2006 reported a 55% success rate [16] . Such reports on the efficacy of PCPS have a large deviation in the success rate.
Such a deviation resulted from the study design of the patient group, and the timing of application and techniques related to operation and maintenance of PCPS, which differed in among various centers [17] . Our study results show a lower survival rate and weaning rate than studies carried out in other centers. It seems that setting the patient group exhibiting cardiogenic shock or cardiac arrest as the study target would be the most determinant factor affecting the study results. Also, p-ECMO may play a role in enabling surgical treatment for those with very unstable vital conditions. However, it still does have a limited effect on advanced cardiac diseases. Reichman et al. [12] reported that out of 38 cardiac arrest cases in which PCPS was used due to acute myocardial infarction, 7 survivors received CABG, and only 3 were reported to have survived long-term Early reports by Matsuwaka et al. [13] and Suarez et al. [14] demonstrated the supportive role of PCPS in cardiogenic shock due to acute cardiovascular diseases. Despite the low survival rate in the early reports, a gradual accumulation in clinical reports followed an increase in survival rates, elicited by improved skill of the operator and advancement of PCPS. In regard to the broad gap in the survival rate among different centers, it will be necessary to carry out a multicenter study on the use of PCPS in order to impose specific guidelines for use.
However, the most important reason for having a large gap in the survival rate results is probably due to variations in the composition of the patient groups [17] .
This study indicated that only 19 out of 41 patients (46.3%) were able to be weaned from p-ECMO, which is not much better than other studies. Also, only a total of 9 patients (21.9%) showed long-term survival. This is probably due to setting up a study group composed of patients with very unstable hemodynamics, such as cardiogenic shock or cardiac arrest. Our study also included patients not only with coronary heart disease but also aortic diseases, valvular diseases, cardiomyopathy, and other diseases that were excluded in other studies. This might have affected the study result of Unless decompression of the left atrium is achieved, recovery of the left ventricle may be hindered [23] . If a better clinical manifestation is expected, aggressive use of IABP combined with use of PCPS should be considered for recovery of cardiac function [24] .
Usually the vascular connection for p-ECMO is veno-arterial (V-A ECMO) or veno-venous (V-V ECMO), and in our study, V-A p-ECMO was used for all cases. For most cases a venous catheter can be inserted into the internal jugular vein, right atrium, or femoral vein, and an arterial catheter can be inserted into the right carotid artery, axillary artery, femoral artery, or aorta. V-A p-ECMO can help gas exchange and cardiac output, whereas V-V p-ECMO can only support gas exchange [25] . Shown in our study, V-A p-ECMO can aid cardiac function. It also exhibits the advantage of relatively easy access through the carotid artery in both adults and infants. Nonetheless, Ligation of the catotid artery is sometimes necessary during this procedure and it has high risk of developing cerebrovascular complications. Blood flow to the entire body cannot be sent in a pulsatile mode. If pulmonary function is severely deteriorated, the oxygen saturation of the blood running from the left ventricle to the coronary artery would be much lower than the oxygen saturation obtained from peripheral blood gas analysis. This might cause cardiac failure due to inadequate perfusion to the myocardium. If respiratory support is the sole purpose of using PCPS and if there is no abnormality observed in cardiac function, V-V p-ECMO can be applied [26] . Furthermore, if typical V-A p-ECMO cannot provide adequate perfusion to the myocardium, a change to or combined use with V-V p-ECMO may increase not only oxygen saturation of the entire body but also that of the myocardium [27] .
CONCLUSION
Despite using a retrospective study with a small sample size, an aggressive approach to surgical treatment, an invasive procedure using PCPS is indispensable for patients with lethal 
